271. Ankylosing spondylitis Clinical trials / Disease details


Clinical trials : 574 Drugs : 359 - (DrugBank : 68) / Drug target genes : 41 - Drug target pathways : 146

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02528201
(ClinicalTrials.gov)
September 200218/6/2015A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing SpondylitisA Twelve Week, Randomized, Double Blind Parallel Group Study Of Two Doses Of Celecoxib Compared To Diclofenac In Patients With Ankylosing SpondylitisAnkylosing SpondylitisDrug: Celecoxib 200 milligrams;Drug: Celecoxib 400 milligrams;Drug: diclofenac 50 milligramsPfizerNULLCompleted18 Years75 YearsBoth330Phase 4Norway